Portal Hypertensive Biliopathy as a Cause of Severe Cholestasis in Children With Congenital Hepatic Fibrosis


DALGIÇ A. , SARI S. , SÖZEN M. H. , Kaya N. G. , DALGIÇ B.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION, cilt.17, ss.223-225, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 17
  • Basım Tarihi: 2019
  • Doi Numarası: 10.6002/ect.mesot2018.p79
  • Dergi Adı: EXPERIMENTAL AND CLINICAL TRANSPLANTATION
  • Sayfa Sayıları: ss.223-225

Özet

Portal hypertensive biliopathy may occur in patients with noncirrhotic hepatic fibrosis. Portal hypertensive biliopathy treatment should be focused on management of portal hypertension and relief of biliary obstruction. In patients with noncirrhotic portal fibrosis and symptomatic portal hypertensive biliopathy, portal decompression surgery by proximal splenorenal shunt is one successful treatment option.